Although our study did not find a significant correlation between the TIPE3 expression and the number of tumor-infiltrating immune cells, a Cox regression analysis showed that the TIPE3 expression and CD8+ T cells jointly affect patient survival (Table 3 and Supplementary Fig. 2), suggesting they have significant prospects for clinical applications as prognostic indicators. The gene discussed is TIPE3; the disease is neoplasm.